ProfileGDS4718 / 208710_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 96% 93% 90% 92% 95% 94% 91% 84% 85% 86% 94% 94% 93% 95% 84% 83% 93% 94% 99% 94% 91% 85% 84% 95% 94% 81% 96% 86% 95% 94% 94% 93% 84% 91% 91% 93% 93% 91% 90% 86% 92% 92% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0522789
GSM549102patient 115, normal, homogenized [OPG study]10.417396
GSM549104patient 119, normal, homogenized [OPG study]9.8125793
GSM549108patient 138, normal, homogenized [OPG study]9.1311690
GSM549119patient 077, normal, homogenized [OPG study]9.5485792
GSM549133patient 032, cancer, homogenized [OPG study]10.226495
GSM549139patient 042, cancer, homogenized [OPG study]9.8635394
GSM549099patient 107, normal, homogenized [OPG study]9.4151191
GSM549109patient 139, normal, homogenized [OPG study]8.346584
GSM549110patient 046, normal, homogenized [OPG study]8.4312385
GSM549114patient 063, normal, homogenized [OPG study]8.7904386
GSM549122patient 082, normal, homogenized [OPG study]10.036794
GSM549134patient 033, cancer, homogenized [OPG study]10.084794
GSM549136patient 036, cancer, homogenized [OPG study]9.861693
GSM549140patient 044, cancer, homogenized [OPG study]10.254295
GSM549111patient 047, normal, homogenized [OPG study]8.3795884
GSM549113patient 057, normal, homogenized [OPG study]8.2842483
GSM549132patient 031, cancer, homogenized [OPG study]9.7716293
GSM549137patient 038, cancer, homogenized [OPG study]9.841894
GSM549142patient 047, cancer, homogenized [OPG study]11.882699
GSM549100patient 110, normal, homogenized [OPG study]9.9300494
GSM549107patient 135, normal, homogenized [OPG study]9.5073891
GSM549115patient 068, normal, homogenized [OPG study]8.5932985
GSM549116patient 072, normal, homogenized [OPG study]8.3683784
GSM549120patient 078, normal, homogenized [OPG study]10.176695
GSM549131patient 030, cancer, homogenized [OPG study]10.044794
GSM549118patient 074, normal, homogenized [OPG study]7.9947781
GSM549129patient 027, cancer, homogenized [OPG study]10.159796
GSM549123patient 088, normal, homogenized [OPG study]8.6147586
GSM549124patient 006, cancer, homogenized [OPG study]9.9359595
GSM549126patient 015, cancer, homogenized [OPG study]9.7997594
GSM549128patient 025, cancer, homogenized [OPG study]9.8850494
GSM549103patient 117, normal, homogenized [OPG study]9.6498193
GSM549117patient 073, normal, homogenized [OPG study]8.414984
GSM549138patient 041, cancer, homogenized [OPG study]9.2875891
GSM549141patient 045, cancer, homogenized [OPG study]9.4014791
GSM549130patient 028, cancer, homogenized [OPG study]9.6786493
GSM549101patient 111, normal, homogenized [OPG study]9.7453793
GSM549105patient 128, normal, homogenized [OPG study]9.3082491
GSM549106patient 134, normal, homogenized [OPG study]9.4200190
GSM549112patient 048, normal, homogenized [OPG study]8.5729886
GSM549125patient 011, cancer, homogenized [OPG study]9.5484292
GSM549127patient 024, cancer, homogenized [OPG study]9.4224292
GSM549135patient 035, cancer, homogenized [OPG study]9.7171993